Off-label Avastin linked to 36 eye inflammation cases in Canada
This article was originally published in Scrip
Executive Summary
Genentechhas notified physicians of 36 cases of eye inflammation among patients who were receiving injections of the company's anticancer Avastin (bevacizumab) off-label.